Novartis and IKN set record with Human Pink Ribbon

Novartis Malaysia, in collaboration with Institut Kanser Negara (IKN), entered the Malaysia Book of Records for creating the Largest Human Pink Ribbon. This significant milestone aims to heighten breast cancer awareness and foster solidarity among patients and supporters.

This record-breaking attempt served as the highlight of IKN’s annual Pink Carnival celebration, with 2,050 supporters dressed in pink gathering at Institut Kanser Negara to form the human ribbon.

The event was officiated by Deputy Prime Minister Dato’ Sri Fadillah Yusof, who acknowledged the record-breaking achievement. He praised the formation as a powerful symbol of solidarity, resilience, and support for breast cancer patients and survivors.

Rising breast cancer rates demand urgent attention

Breast cancer remains the most prevalent form of cancer among Malaysians, with one in five cancer diagnoses being breast cancer. According to Minister of Health Malaysia, Datuk Seri Dr. Dzulkefly Ahmad, breast cancer is the leading cause of death among Malaysian women, with an alarming rise in late-stage diagnoses. Citing the National Cancer Registry Report 2017-2021, Dr. Dzulkefly noted that 50.5% of cases were detected at advanced stages (Stage 3 or 4). He underscored the need for heightened public awareness and early detection initiatives.

Dr. Mohamed Anis Harun, Director of IKN, emphasized the significance of this record-breaking event as a testament to the importance of early detection and a supportive network for breast cancer patients. “By working together, we can significantly improve treatment outcomes and save lives. This powerful visual statement aims to inspire and empower all Malaysian breast cancer patients, reminding them that they are not alone in their fight,” he remarked.

Living Well, Living Together

Key partners like Novartis Malaysia have played a vital role in advancing breast cancer care. Jegatheswaran Panderengen, Country Head of Public Affairs at Novartis Malaysia, expressed the organization’s commitment to enhancing treatment and quality of life for Malaysian patients. Since 2022, Novartis has partnered closely with IKN, promoting community initiatives, educational programs, and innovative therapies to support patients.

Datin Dr. Zuhanis binti Abdul Hamid, Chairman of the Persatuan Pendidikan Perubatan Institut Kanser Negara (PPPIKN), highlighted the importance of a strong support network for cancer patients. “It is crucial for these patients to have a comprehensive support network which includes medical organizations, oncologists, and dedicated corporate partners like Novartis Malaysia. We deeply appreciate Novartis’ continuous and unwavering support in helping to elevate the patient experience for those battling breast cancer in Malaysia” she said.

As the event concluded, attendees were urged to continue rallying together, championing the spirit of “Living Well, Living Together”. The gathering showcased the strength and resilience that collective hope can inspire. This unity highlighted the power of solidarity in facing and overcoming the challenges of this disease.